• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝炎的肝活检评估

Liver biopsy assessment in chronic hepatitis.

作者信息

Lefkowitch Jay H

机构信息

Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

出版信息

Arch Med Res. 2007 Aug;38(6):634-43. doi: 10.1016/j.arcmed.2006.08.005.

DOI:10.1016/j.arcmed.2006.08.005
PMID:17613355
Abstract

Liver biopsy has been a major diagnostic tool in the evaluation of individuals with chronic hepatitis for many decades and remains the most direct way of visualizing hepatic necroinflammation and fibrosis. In chronic viral hepatitis B and C, immune attack on hepatocytes bearing viral antigens results in the entry of lymphocytes and other effector cells through the portal tracts from which other lesions may evolve, including interface and lobular hepatitis as well as fibrosis or cirrhosis. Classification systems have been developed in order to provide semiquantitative grading of necroinflammation and staging of fibrosis and include the Scheuer, Batts and Ludwig, Ishak, and METAVIR systems. This review provides an historical perspective on histopathological methods of analyzing chronic hepatitis, describes the essential criteria of each of the major scoring systems and discusses problems related to sampling error, observer variation, and specimen size.

摘要

几十年来,肝活检一直是评估慢性肝炎患者的主要诊断工具,并且仍然是观察肝脏坏死性炎症和纤维化的最直接方法。在慢性乙型和丙型病毒性肝炎中,对携带病毒抗原的肝细胞的免疫攻击导致淋巴细胞和其他效应细胞通过门静脉进入,其他病变可能由此演变而来,包括界面性肝炎和小叶性肝炎以及纤维化或肝硬化。为了对坏死性炎症进行半定量分级和对纤维化进行分期,已经开发了多种分类系统,包括Scheuer、Batts和Ludwig、Ishak以及METAVIR系统。本综述提供了分析慢性肝炎的组织病理学方法的历史视角,描述了每个主要评分系统的基本标准,并讨论了与抽样误差、观察者差异和标本大小相关的问题。

相似文献

1
Liver biopsy assessment in chronic hepatitis.慢性肝炎的肝活检评估
Arch Med Res. 2007 Aug;38(6):634-43. doi: 10.1016/j.arcmed.2006.08.005.
2
Operational scores in the diagnosis of chronic hepatitis. A semi-quantitative assessment.慢性肝炎诊断中的操作评分。一项半定量评估。
Rom J Morphol Embryol. 2012;53(1):81-7.
3
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.慢性丙型肝炎病毒感染患者肝活检中的抽样误差和观察者内变异
Am J Gastroenterol. 2002 Oct;97(10):2614-8. doi: 10.1111/j.1572-0241.2002.06038.x.
4
Chronic viral hepatitis: the histology report.慢性病毒性肝炎:组织学报告。
Dig Liver Dis. 2011 Mar;43 Suppl 4:S331-43. doi: 10.1016/S1590-8658(11)60589-6.
5
Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.组织学检查结果的替代指标:血清透明质酸用于评估慢性病毒性肝炎中的纤维化,高敏C反应蛋白用于评估坏死性炎症。
Int J Clin Pract. 2007 Mar;61(3):438-43. doi: 10.1111/j.1742-1241.2006.00912.x.
6
Sampling variability of liver fibrosis in chronic hepatitis C.慢性丙型肝炎中肝纤维化的抽样变异性
Hepatology. 2003 Dec;38(6):1449-57. doi: 10.1016/j.hep.2003.09.022.
7
Actualities in the histopathological interpretation of chronic hepatitis. A review of the main classifications.
Rom J Morphol Embryol. 1998 Jan-Dec;44(1-4):35-44.
8
Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies.丙型肝炎患者从慢性肝炎到肝硬化的纤维化长期演变:重复活检的形态计量学分析
Hepatology. 1997 Apr;25(4):1028-31. doi: 10.1002/hep.510250439.
9
[Comparison of the different methods of grading and staging of chronic hepatitis].[慢性肝炎不同分级和分期方法的比较]
Pathologica. 1996 Aug;88(4):263-9.
10
The long-term pathological evolution of chronic hepatitis C.慢性丙型肝炎的长期病理演变
Hepatology. 1996 Jun;23(6):1334-40. doi: 10.1002/hep.510230607.

引用本文的文献

1
Comparative Evaluation of the Degree of Liver Fibrosis on Ultrasound-Based Fibroscan and Hyaluran Tests in Patients with Chronic Liver Disease.基于超声的Fibroscan和透明质酸检测对慢性肝病患者肝纤维化程度的比较评估
J West Afr Coll Surg. 2025 Apr-Jun;15(2):136-141. doi: 10.4103/jwas.jwas_82_23. Epub 2025 Feb 4.
2
Histological Grading and Staging of Chronic Hepatitis.慢性肝炎的组织学分级与分期
Clin Liver Dis (Hoboken). 2021 May 1;17(4):222-226. doi: 10.1002/cld.1014. eCollection 2021 Apr.
3
The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B.
新型 5 种循环 miRNA 模型对慢性乙型肝炎患者肝纤维化的诊断价值。
Mediators Inflamm. 2021 Mar 1;2021:6636947. doi: 10.1155/2021/6636947. eCollection 2021.
4
Dietary modulations of folic acid affect the development of diethylnitrosamine induced hepatocellular carcinoma in a rat model.饮食中叶酸的调节会影响二乙基亚硝胺诱导的大鼠肝癌模型的发展。
J Mol Histol. 2021 Apr;52(2):335-350. doi: 10.1007/s10735-020-09955-9. Epub 2021 Jan 13.
5
Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinoma.肿瘤抑制基因在肝细胞癌大鼠模型中受到膳食叶酸调控的差异调节。
Mol Cell Biochem. 2021 Jan;476(1):385-399. doi: 10.1007/s11010-020-03915-3. Epub 2020 Sep 24.
6
Liver fibrosis is a major risk factor for liver regeneration: A comparison between healthy and fibrotic liver.肝纤维化是肝脏再生的主要危险因素:健康肝脏与纤维化肝脏的比较。
Medicine (Baltimore). 2020 May 29;99(22):e20003. doi: 10.1097/MD.0000000000020003.
7
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.熊去氧胆酸治疗原发性胆汁性胆管炎以预防肝移植或死亡的所需人数。
Gut. 2020 Aug;69(8):1502-1509. doi: 10.1136/gutjnl-2019-319057. Epub 2019 Dec 16.
8
Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy.预测性验证抗病毒治疗的慢性乙型肝炎患者的定性纤维化分期。
Sci Rep. 2019 Oct 30;9(1):15628. doi: 10.1038/s41598-019-51638-3.
9
Patterns of necrosis in liver disease.肝脏疾病中的坏死模式。
Clin Liver Dis (Hoboken). 2017 Aug 30;10(2):53-56. doi: 10.1002/cld.653. eCollection 2017 Aug.
10
Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease.体细胞突变增加慢性肝病中的肝克隆适应性和再生。
Cell. 2019 Apr 18;177(3):608-621.e12. doi: 10.1016/j.cell.2019.03.026. Epub 2019 Apr 4.